Peter Attia· MD
in a mammal or in a person the anti-inflammatory effects account for many maybe most of the functional benefits that we see when we treat an old organism old animal
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in a mammal or in a person the anti-inflammatory effects account for many maybe most of the functional benefits that we see when we treat an old organism old animal
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I'll bring it back to inflammation. You need mTor on when you wound your skin or you get an infection or you have a big meal in your liver, but you need it off the rest of the time. And when you're young, you're very good at maintaining that dynamic range. But what's happening with aging, at least in stem cells, is that the baseline levels of mTor creeping up.
Uh you know one of the things we were one of the earliest people to publish was that what's happening during aging is that baseline levels of mtor are creeping up. You can't turn the pathway off.